Autoimmune Disease Diagnosis Market by Products (Consumables  Assay Kits  Instruments  Services)  Test Type (Inflammatory Markers  Autoantibodies)  Disease (RA  SLE  Thyroiditis  Scleroderma)  End Users (Hospitals  Clinical Labs) - Global Forecast to 2022

Autoimmune Disease Diagnosis Market by Products (Consumables Assay Kits Instruments Services) Test Type (Inflammatory Markers Autoantibodies) Disease (RA SLE Thyroiditis Scleroderma) End Users (Hospitals Clinical Labs) - Global Forecast to 2022

MarketsandMarkets | ID: 1524124745770 | Published at: 2018-01-29 | Pages: 123

  • €4.785,63


“The autoimmune disease diagnosis market projected to grow at a CAGR of 8.9% during the forecast period.”
The global autoimmune disease diagnosis market is expected to reach USD 4.73 billion by 2022 from USD 3.09 billion in 2017, at a CAGR of 8.9%. Factors driving the growth of this market include the rising incidence of autoimmune diseases, growing healthcare expenditure, increasing access to medical insurance in the US, and technological advancements in diagnosis devices. On the other hand, the high cost of analyzers and other instruments is expected to challenge market growth to a certain extent.
“The consumables and assay kits segment is anticipated to grow at the fastest growth rate during the forecast period.”
The autoimmune disease diagnosis market by product and service is categorized into consumables & assay kits, instruments, and services. The consumables and assay kits segment is expected to register the highest CAGR during the forecast period. The growing adoption of consumables and assay kits for the diagnosis of autoimmune diseases is the key factors driving the growth of this market.
“The routine laboratory tests segment is anticipated to grow at the fastest growth rate during the forecast period.”
The autoimmune disease diagnosis market by test type is categorized into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. The routine laboratory test segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly driven by the increasing adoption of routine laboratory tests for a variety of diseases.
“The rheumatoid arthritis segment is anticipated to grow at the fastest growth rate during the forecast period.”
The autoimmune disease diagnosis market by disease is categorized into systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome, thyroiditis, scleroderma, and other diseases. The rheumatoid arthritis segment is expected to register the highest CAGR during the forecast period. The growing use of instruments and consumables for the diagnosis and treatment of rheumatoid arthritis, increasing awareness regarding autoimmune diseases, and the development of novel products are the key factors driving the growth of this market.
“The clinical laboratories segment is estimated to grow at a rapid rate during the forecast period”
By end user, the autoimmune disease diagnosis market is segmented into clinical laboratories, hospitals, and other end users. The clinical laboratories segment is expected to grow at highest CAGR during the forecast period. Factors such as the rising number of patients suffering from autoimmune diseases and improving healthcare infrastructure are driving the growth of this segment.
“Asia is estimated to grow at the highest CAGR during the forecast period”
Geographically, the autoimmune disease diagnosis market is dominated by North America, followed by Europe in 2017, however, Asia is estimated to grow at the fastest rate during the forecast period. Growth in this region can be attributed to developing healthcare infrastructure, rising burden of autoimmune diseases, and increasing initiatives to promote the use of novel technologies for autoimmune disease diagnosis in Asian countries.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1 – 70% and Tier 2 – 30%
• By Designation – C level – 62%, Director level – 21%, Others – 17%
• By Region – North America – 50%, Asia– 30%, Europe – 20%

The key players in the autoimmune disease diagnosis market include Thermo Fisher Scientific. (US), Danaher (US), HYCOR Biomedical (US), Siemens (Germany), Bio-Rad (US), Inova Diagnostics (US), Trinity Biotech (Ireland), GRIFOLS. (Spain), and Abbott (US).
Research Coverage:
The report analyses the autoimmune disease diagnosis market by product, test type, disease, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.
Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the autoimmune disease diagnosis market
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the autoimmune disease diagnosis market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the autoimmune disease diagnosis market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various autoimmune disease diagnosis and services across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the autoimmune disease diagnosis market.

TABLE OF CONTENTS

1 INTRODUCTION 13

  • 1.1 OBJECTIVES OF THE STUDY 13
  • 1.2 DEFINITION 13
  • 1.3 STUDY SCOPE 14
  • 1.4 YEARS CONSIDERED FOR THE STUDY 14
  • 1.5 CURRENCY 15
  • 1.6 LIMITATIONS 15
  • 1.7 STAKEHOLDERS 15
    2 RESEARCH METHODOLOGY 16
  • 2.1 RESEARCH DATA 17
    • 2.1.1 SECONDARY DATA 17
      • 2.1.1.1 Secondary sources 17
    • 2.1.2 PRIMARY DATA 17
      • 2.1.2.1 Key data from primary sources 18
      • 2.1.2.2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY type, DESIGNATION, and region 18
  • 2.2 MARKET SIZE ESTIMATION 19
    • 2.2.1 BOTTOM-UP APPROACH 19
    • 2.2.2 TOP-DOWN APPROACH 20
  • 2.3 DATA TRIANGULATION 21
    3 EXECUTIVE SUMMARY 23
    4 PREMIUM INSIGHTS 27
  • 4.1 ATTRACTIVE MARKET OPPORTUNITIES IN AUTOIMMUNE DISEASE DIAGNOSIS MARKET 27
  • 4.2 ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 28
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET 29
  • 4.4 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 30
    5 MARKET OVERVIEW 31
  • 5.1 INTRODUCTION 31
  • 5.2 MARKET DYNAMICS 31
    • 5.2.1 DRIVERS 32
      • 5.2.1.1 High incidence and large economic burden of autoimmune diseases 32
      • 5.2.1.2 Increasing access to medical insurance in the US 32
    • 5.2.2 RESTRAINTS 33
      • 5.2.2.1 High capital requirements 33
    • 5.2.3 OPPORTUNITIES 33
      • 5.2.3.1 Growth opportunities in emerging countries 33
      • 5.2.3.2 Increasing number of awareness programs for autoimmune diseases 33
    • 5.2.4 TRENDS 34
      • 5.2.4.1 Growth in the number of reagent rental agreements 34
        6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE 35
  • 6.1 INTRODUCTION 36
  • 6.2 CONSUMABLES AND ASSAY KITS 37
  • 6.3 INSTRUMENTS 38
  • 6.4 SERVICES 39
    7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE 40
  • 7.1 INTRODUCTION 41
  • 7.2 ROUTINE LABORATORY TESTS 42
  • 7.3 INFLAMMATORY MARKERS 42
  • 7.4 AUTOANTIBODIES AND IMMUNOLOGIC TESTS 43
  • 7.5 OTHER TESTS 44
    8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE 45
  • 8.1 INTRODUCTION 46
  • 8.2 RHEUMATOID ARTHRITIS 47
  • 8.3 SYSTEMIC LUPUS ERYTHEMATOSUS 47
  • 8.4 SJÖGREN’S SYNDROME 48
  • 8.5 THYROIDITIS 49
  • 8.6 SCLERODERMA 50
  • 8.7 OTHER DISEASES 50
    9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER 52
  • 9.1 INTRODUCTION 53
  • 9.2 CLINICAL LABORATORIES 54
  • 9.3 HOSPITALS 54
  • 9.4 OTHER END USERS 55
    10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION 57
  • 10.1 INTRODUCTION 58
  • 10.2 NORTH AMERICA 59
    • 10.2.1 US 63
    • 10.2.2 CANADA 65
  • 10.3 EUROPE 67
  • 10.4 ASIA 70
    • 10.4.1 CHINA 74
    • 10.4.2 JAPAN 76
    • 10.4.3 INDIA 78
    • 10.4.4 REST OF ASIA (ROA) 80
  • 10.5 REST OF THE WORLD 82
    11 COMPETITIVE LANDSCAPE 85
  • 11.1 OVERVIEW 85
  • 11.2 MARKET SHARE ANALYSIS, 2016 86
  • 11.3 COMPETITIVE SCENARIO 87
    • 11.3.1 PRODUCT LAUNCHES 87
    • 11.3.2 PARTNERSHIPS 88
    • 11.3.3 ACQUISITIONS 88
    • 11.3.4 COLLABORATIONS 88
      12 COMPANY PROFILES 89
      (Business Overview, Products Offered, MnM View.)*
  • 12.1 SIEMENS 89
  • 12.2 ABBOTT 91
  • 12.3 THERMO FISHER SCIENTIFIC 94
  • 12.4 DANAHER 97
  • 12.5 BIO-RAD LABORATORIES 100
  • 12.6 GRIFOLS 102
  • 12.7 TRINITY BIOTECH 104
  • 12.8 INOVA DIAGNOSTICS 106
  • 12.9 HYCOR BIOMEDICAL 108
  • 12.10 EUROIMMUN 110
  • 12.11 PROTAGEN 111
*Business Overview, Products Offered, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 112
  • 13.1 INSIGHTS FROM INDUSTRY EXPERTS 112
  • 13.2 DISCUSSION GUIDE 113
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 116
  • 13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 118
  • 13.5 AVAILABLE CUSTOMIZATIONS 119
  • 13.6 RELATED REPORTS 120
  • 13.7 AUTHOR DETAILS 121

LIST OF TABLES

TABLE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCTS & SERVICES,
2015–2022 (USD MILLION) 36
TABLE 2 AUTOIMMUNE DISEASE DIAGNOSIS CONSUMABLES AND ASSAY KITS MARKET,
BY REGION, 2015–2022 (USD MILLION) 37
TABLE 3 AUTOIMMUNE DISEASE DIAGNOSIS INSTRUMENTS MARKET, BY REGION,
2015–2022 (USD MILLION) 38
TABLE 4 AUTOIMMUNE DISEASE DIAGNOSIS SERVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 39
TABLE 5 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2015–2022 (USD MILLION) 41
TABLE 6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR ROUTINE LABORATORY TESTS, BY REGION, 2015–2022 (USD MILLION) 42
TABLE 7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR INFLAMMATORY MARKERS,
BY REGION, 2015–2022 (USD MILLION) 43
TABLE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR AUTOANTIBODIES AND IMMUNOLOGIC TESTS, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER TESTS, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 46
TABLE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR RHEUMATOID ARTHRITIS,
BY REGION, 2015–2022 (USD MILLION) 47
TABLE 12 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SLE, BY REGION,
2015–2022 (USD MILLION) 48
TABLE 13 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SJÖGREN’S SYNDROME,
BY REGION, 2015–2022 (USD MILLION) 48
TABLE 14 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR THYROIDITIS, BY REGION,
2015–2022 (USD MILLION) 49
TABLE 15 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SCLERODERMA, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER DISEASES, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 17 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2015–2022 (USD MILLION) 53
TABLE 18 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR CLINICAL LABORATORIES,
BY REGION, 2015–2022 (USD MILLION) 54
TABLE 19 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR HOSPITALS, BY REGION,
2015–2022 (USD MILLION) 55
TABLE 20 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION) 56
TABLE 21 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION,
2015–2022 (USD MILLION) 59
TABLE 22 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 61
TABLE 23 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT
& SERVICE, 2015–2022 (USD MILLION) 61
TABLE 24 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015–2022 (USD MILLION) 62
TABLE 25 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015–2022 (USD MILLION) 62
TABLE 26 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015–2022 (USD MILLION) 63
TABLE 27 US: AUTOIMMUNE DISEASE PREVALENCE, 2016 63
TABLE 28 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 64
TABLE 29 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2015–2022 (USD MILLION) 64
TABLE 30 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 65
TABLE 31 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2015–2022 (USD MILLION) 65
TABLE 32 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION) 66
TABLE 33 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2015–2022 (USD MILLION) 66
TABLE 34 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 67
TABLE 35 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2015–2022 (USD MILLION) 67
TABLE 36 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION) 68
TABLE 37 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2015–2022 (USD MILLION) 69
TABLE 38 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 69
TABLE 39 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2015–2022 (USD MILLION) 70
TABLE 40 ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY,
015–2022 (USD MILLION) 72
TABLE 41 ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION) 72
TABLE 42 ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2015–2022 (USD MILLION) 72
TABLE 43 ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 73
TABLE 44 ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2015–2022 (USD MILLION) 74
TABLE 45 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION) 74
TABLE 46 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2015–2022 (USD MILLION) 75
TABLE 47 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 75
TABLE 48 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2015–2022 (USD MILLION) 76
TABLE 49 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION) 76
TABLE 50 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2015–2022 (USD MILLION) 77
TABLE 51 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 77
TABLE 52 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2015–2022 (USD MILLION) 78
TABLE 53 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION) 78
TABLE 54 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2015–2022 (USD MILLION) 79
TABLE 55 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 79
TABLE 56 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2015–2022 (USD MILLION) 80
TABLE 57 ROA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION) 80
TABLE 58 ROA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2015–2022 (USD MILLION) 81
TABLE 59 ROA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 81
TABLE 60 ROA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2015–2022 (USD MILLION) 82
TABLE 61 ROW: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION) 82
TABLE 62 ROW: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2015–2022 (USD MILLION) 83
TABLE 63 ROW: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 83
TABLE 64 ROW: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2015–2022 (USD MILLION) 84


LIST OF FIGURES

FIGURE 1 MARKET SEGMENTATION 14
FIGURE 2 RESEARCH DESIGN 16
FIGURE 3 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: BOTTOM-UP APPROACH 19
FIGURE 4 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: TOP-DOWN APPROACH 20
FIGURE 5 DATA TRIANGULATION METHODOLOGY 21
FIGURE 6 ASSUMPTIONS 22
FIGURE 7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCTS & SERVICES,
2017 VS. 2022 (USD MILLION) 23
FIGURE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,
2017 VS. 2022 (USD MILLION) 24
FIGURE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,
2017 VS. 2022 (USD MILLION) 25
FIGURE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,
2017 VS. 2022 (USD MILLION) 25
FIGURE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION,
2017 VS. 2022 (USD MILLION) 26
FIGURE 12 HIGH INCIDENCE & LARGE ECONOMIC BURDEN OF AUTOIMMUNE DISEASES—MAJOR FACTOR EXPECTED TO DRIVE MARKET GROWTH 27
FIGURE 13 ROUTINE LABORATORY TESTS SEGMENT TO DOMINATE THE ASIAN AUTOIMMUNE DISEASE DIAGNOSIS MARKET IN 2017 28
FIGURE 14 NORTH AMERICA TO ACCOUNT THE HIGHEST MARKET SHARE IN 2017 29
FIGURE 15 CLINICAL LABORATORIES TO DOMINATE THE AUTOIMMUNE DISEASE DIAGNOSIS MARKET IN 2017 30
FIGURE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS 31
FIGURE 17 CONSUMABLES AND ASSAY KITS TO FORM THE LARGEST PRODUCT SEGMENT
IN 2017 36
FIGURE 18 ROUTINE LABORATORY TESTS TO FORM THE LARGEST TEST TYPE SEGMENT
IN 2017 41
FIGURE 19 RHEUMATOID ARTHRITIS TO FORM THE LARGEST DISEASE SEGMENT IN 2017 46
FIGURE 20 CLINICAL LABORATORIES TO FORM THE LARGEST END-USER SEGMENT IN 2017 53
FIGURE 21 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION,
2017 VS. 2022 (USD MILLION) 58
FIGURE 22 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT 60
FIGURE 23 CONSUMABLES & ASSAY KITS TO DOMINATE THE NORTH AMERICAN AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, IN 2017 61
FIGURE 24 ROUTINE LABORATORY TESTS TO DOMINATE THE EUROPEAN AUTOIMMUNE DISEASE DIAGNOSIS MARKET IN 2017 68
FIGURE 25 ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT 71
FIGURE 26 RHEUMATOID ARTHRITIS TO DOMINATE THE ASIAN AUTOIMMUNE DISEASE DIAGNOSIS MARKET IN 2017 73
FIGURE 27 CLINICAL LABORATORIES SEGMENT TO REGISTER THE HIGHEST GROWTH RATE IN THE ROW AUTOIMMUNE DISEASE DIAGNOSIS MARKET BETWEEN 2017 & 2022 84
FIGURE 28 PRODUCT LAUNCHES, THE MOST ADOPTED GROWTH STRATEGY FROM
2014 TO 2017 85
FIGURE 29 SHARES OF TOP COMPANIES IN THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET 2016 86
FIGURE 30 SIEMENS: COMPANY SNAPSHOT 89
FIGURE 31 ABBOTT: COMPANY SNAPSHOT 91
FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 94
FIGURE 33 DANAHER: COMPANY SNAPSHOT 97
FIGURE 34 BIO-RAD LABORATORIES: COMPANY SNAPSHOT 100
FIGURE 35 GRIFOLS: COMPANY SNAPSHOT 102
FIGURE 36 TRINITY BIOTECH: COMPANY SNAPSHOT 104

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!